PT  - JOURNAL ARTICLE
AU  - MICHELANGELO RUSSILLO
AU  - GIANLUIGI FERRETTI
AU  - ANTONELLO VIDIRI
AU  - SIMONA GASPARRO
AU  - FRANCESCO COGNETTI
AU  - DOMENICA PELLEGRINI
AU  - ALESSANDRA FABI
TI  - Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain Metastasis
AID  - 10.21873/invivo.11317
DP  - 2018 Jul 01
TA  - In Vivo
PG  - 839--842
VI  - 32
IP  - 4
4099  - http://iv.iiarjournals.org/content/32/4/839.short
4100  - http://iv.iiarjournals.org/content/32/4/839.full
SO  - In Vivo2018 Jul 01; 32
AB  - This is a case report of a 40-year-old woman who, after conservative breast cancer treatment, developed a HER2 positive solitary brain metastasis in the left temporal lobe, without extracranial disease. She underwent surgery resection followed by stereotactic radiotherapy and, because of early brain progression, she was submitted to the first line therapy with pertuzumab, trastuzumab and weekly paclitaxel. After six months of treatment, a brain magnetic resonance imaging revealed a complete disappearance of brain recurrence, which persisted for more than 24 months.